364 results on '"van Herpen, Carla M. L."'
Search Results
2. Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients
3. Exposure–response analyses of cabozantinib in patients with metastatic renal cell cancer
4. Patients with Rare Head Neck Cancers: Do They Need a Different Approach?
5. Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey
6. Experiences of bereaved family caregivers with shared decision making in palliative cancer treatment: a qualitative interview study
7. The solitary versus supported experience: Care inequality between rare and common cancer patients
8. Pan-cancer whole-genome analyses of metastatic solid tumours
9. Caregivers’ burden and fatigue during and after patients’ treatment with concomitant chemoradiotherapy for locally advanced head and neck cancer: a prospective, observational pilot study
10. Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study
11. Dose recommendations for anticancer drugs in patients with renal or hepatic impairment
12. Correlation between Histopathological Prognostic Tumor Characteristics and [ 18 F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer.
13. Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
14. Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane
15. Everolimus Exposure and Early Metabolic Response as Predictors of Treatment Outcomes in Breast Cancer Patients Treated with Everolimus and Exemestane
16. A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer
17. The Prognostic Relevance of MRI Characteristics in Myxofibrosarcoma Patients Treated with Neoadjuvant Radiotherapy
18. Molecular tumour boards and molecular diagnostics for patients with cancer in the Netherlands: experiences, challenges, and aspirations
19. Quality of life of patients with locally advanced head and neck cancer treated with induction chemotherapy followed by cisplatin-containing chemoradiotherapy in the Dutch CONDOR study: a randomized controlled trial
20. Methylated Cell-Free DNA Sequencing (MeD-seq) of LpnPI Digested Fragments to Identify Early Progression in Metastatic Renal Cell Carcinoma Patients on Watchful Waiting
21. Lean Body Mass and Total Body Weight Versus Body Surface Area as a Determinant of Docetaxel Pharmacokinetics and Toxicity
22. Results of histopathological revisions of major salivary gland neoplasms in routine clinical practice.
23. Identification of Fusion Genes and Targets for Genetically Matched Therapies in a Large Cohort of Salivary Gland Cancer Patients
24. Psychosocial Aspects of Living Long Term with Advanced Cancer and Ongoing Systemic Treatment: A Scoping Review
25. Androgen deprivation therapy for androgen receptor‐positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands
26. Optimizing the dose in cancer patients treated with imatinib, sunitinib and pazopanib
27. Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands
28. Olaparib tablet formulation: effect of food on the pharmacokinetics after oral dosing in patients with advanced solid tumours
29. Sunitinib does not attenuate contractile force following a period of ischemia in isolated human cardiac muscle
30. Impact of chemotherapy on the outcome of osteosarcoma of the head and neck in adults
31. Results of histopathological revisions of major salivary gland neoplasms in routine clinical practice
32. Temsirolimus and pegylated liposomal doxorubicin (PLD) combination therapy in breast, endometrial, and ovarian cancer: phase Ib results and prediction of clinical outcome with FDG-PET/CT
33. Diagnostic challenges of respiratory adverse events during everolimus treatment
34. Correlation of toxicity and efficacy with pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD) (Caelyx®)
35. Case Report: Two Cases of Salivary Duct Carcinoma in Workers With a History of Chromate Exposure
36. Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer
37. Toxicity and efficacy of accelerated radiotherapy with concurrent weekly cisplatin for locally advanced head and neck carcinoma
38. Normalcy of food intake in patients with head and neck cancer supported by combined dietary counseling and swallowing therapy: A randomized clinical trial
39. The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinoma
40. Low-grade salivary duct carcinoma in the bronchus
41. 89Zr-DFO-durvalumab PET/CT prior to durvalumab treatment in patients with recurrent or metastatic head and neck cancer.
42. Towards a better understanding of immune checkpoint inhibitor radiolabeled PET imaging studies.
43. Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade
44. Cutaneous lymphangitis carcinomatosa in salivary duct carcinoma.
45. Additional file 1 of Experiences of bereaved family caregivers with shared decision making in palliative cancer treatment: a qualitative interview study
46. Additional file 2 of Experiences of bereaved family caregivers with shared decision making in palliative cancer treatment: a qualitative interview study
47. Additional file 1 of Differences in health care experiences between rare cancer and common cancer patients: results from a national cross-sectional survey
48. Nutritional status, food intake, and dysphagia in long-term survivors with head and neck cancer treated with chemoradiotherapy: A cross-sectional study
49. Psychological aspects in patients with advanced cancer receiving lifelong systemic treatment: protocol for a scoping review
50. A phase II study on the efficacy and toxicity of cabozantinib in recurrent/metastatic salivary gland cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.